1. Lippi G, Lima-Oliveira G, Salvagno GL, Montagnana M, Gelati M, Picheth G, et al. Influence of a light meal on routine haematological tests. Blood Transfus. 2010. 8:94–99.
2. Lima-Oliveira G, Salvagno GL, Lippi G, Montagnana M, Scartezini M, Picheth G, et al. Elimination of the venous stasis error for routine coagulation testing by transillumination. Clin Chim Acta. 2011. 412:1482–1484.
3. Lima-Oliveira G, Lippi G, Salvagno GL, Montagnana M, Scartezini M, Guidi GC, et al. Transillumination: a new tool to eliminate the impact of venous stasis during the procedure for the collection of diagnostic blood specimens for routine haematological testing. Int J Lab Hematol. 2011. 33:457–462.
4. Loh TP, Saw S, Chai V, Sethi SK. Impact of phlebotomy decision support application on sample collection errors and laboratory efficiency. Clin Chim Acta. 2011. 412:393–395.
5. Lippi G, Lima-Oliveira G, Nazer SC, Moreira ML, Souza RF, Salvagno GL, et al. Suitability of a transport box for blood sample shipment over a long period. Clin Biochem. 2011. 44:1028–1029.
6. Young DS. Effects of preanalytical variables on clinical laboratory tests. 2007. 3rd ed. Washington, DC: AACC Press.
7. Hallworth M, Hyde K, Cumming A, Peake I. The future for clinical scientists in laboratory medicine. Clin Lab Haematol. 2002. 24:197–204.
8. Clinical Laboratory Standards Institute. CLSI H3-A6 document. Procedures for the collection of diagnostic blood specimens by venipuncture. 2007. 6th ed. Wayne, PA: Clinical Laboratory Standards Institute.
9. Guder WG, Narayanan S, Wisser H, Zawta B. Diagnostic samples: from the patient to the laboratory: the impact of preanalytical variables on the quality of laboratory results. 2009. 4th ed. New York: Wiley-Blackwell.
10. Clinical Laboratory Standards Institute. CLSI H18-A4 document. Procedures for the handling and processing of blood specimens for common laboratory tests. 2010. 4th ed. Wayne, PA: Clinical Laboratory Standards Institute.
11. Ricós C, Alvarez V, Cava F, García-Lario JV, Hernández A, Jiménez CV, et al. Current databases on biological variation: pros, cons and progress. Scand J Clin Lab Invest. 1999. 59:491–500.
12. Guidi GC, Lippi G. Laboratory medicine in the 2000s: programmed death or rebirth? Clin Chem Lab Med. 2006. 44:913–917.
13. Pagni A, Plebani M. The laboratory and the general practitioner. Clin Chim Acta. 1999. 280:13–24.
14. Johnson CD, Mole DR, Pestridge A. Postprandial alkaline tide: does it exist? Digestion. 1995. 56:100–106.
15. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature. 2002. 418:650–654.
16. Korbonits M, Blaine D, Elia M, Powell-Tuck J. Metabolic and hormonal changes during the refeeding period of prolonged fasting. Eur J Endocrinol. 2007. 157:157–166.
17. Cohn JS, McNamara JR, Cohn SD, Ordovas JM, Schaefer EJ. Postprandial plasma lipoprotein changes in human subjects of different ages. J Lipid Res. 1988. 29:469–479.
18. De Feo P, Horber FF, Haymond MW. Meal stimulation of albumin synthesis: a significant contributor to whole body protein synthesis in humans. Am J Physiol. 1992. 263:E794–E799.
19. Caso G, Feiner J, Mileva I, Bryan LJ, Kelly P, Autio K, et al. Response of albumin synthesis to oral nutrients in young and elderly subjects. Am J Clin Nutr. 2007. 85:446–451.
20. Hunter KA, Ballmer PE, Anderson SE, Broom J, Garlick PJ, McNurlan MA. Acute stimulation of albumin synthesis rate with oral meal feeding in healthy subjects measured with [ring-2H5]phenylalanine. Clin Sci (Lond). 1995. 88:235–242.
21. Jefferson LS. Lilly Lecture 1979: role of insulin in the regulation of protein synthesis. Diabetes. 1980. 29:487–496.
22. Ryan MC, Abbasi F, Lamendola C, Carter S, McLaughlin TL. Serum alanine aminotransferase levels decrease further with carbohydrate than fat restriction in insulin-resistant adults. Diabetes Care. 2007. 30:1075–1080.
23. Meyer BH, Scholtz HE, Schall R, Müller FO, Hundt HK, Maree JS. The effect of fasting on total serum bilirubin concentrations. Br J Clin Pharmacol. 1995. 39:169–171.
24. Cowan RE, Thompson RP. Fatty acids and the control of bilirubin levels in blood. Med Hypotheses. 1983. 11:343–351.
25. Al-Rubeaan K, Siddiqui K, Abu Risheh K, Hamsirani R, Alzekri A, Alaseem A, et al. Correlation between serum electrolytes and fasting glucose and Hb1Ac in Saudi diabetic patients. Biol Trace Elem Res. 2011. 144:463–468.
26. Rohrscheib M, Tzamaloukas AH, Ing TS, Siamopoulos KC, Elisaf MS, Murata HG. Serum potassium concentration in hyperglycemia of chronic dialysis. Adv Perit Dial. 2005. 21:102–105.
27. Gozansky DM, Herman RH. Water and sodium retention in the fasted and refed human. Am J Clin Nutr. 1971. 24:869–871.
28. Bloom WL. Inhibition of salt excretion by carbohydrate. Arch Intern Med. 1962. 109:26–32.
29. Fernández-Real JM, López-Bermejo A, Ricart W. Cross-talk between iron metabolism and diabetes. Diabetes. 2002. 51:2348–2354.
30. Ricós C, Cava F, García-Lario JV, Hernández A, Iglesias N, Jiménez CV, et al. The reference change value: a proposal to interpret laboratory reports in serial testing based on biological variation. Scand J Clin Lab Invest. 2004. 64:175–184.
32. Cembrowski GS, Tran DV, Higgins TN. The use of serial patient blood gas, electrolyte and glucose results to derive biologic variation: a new tool to assess the acceptability of intensive care unit testing. Clin Chem Lab Med. 2010. 48:1447–1454.
33. Plebani M, Lippi G. Biological variation and reference change values: an essential piece of the puzzle of laboratory testing. Clin Chem Lab Med. 2012. 50:189–190.
34. Boldt J. Use of albumin: an update. Br J Anaesth. 2010. 104:276–284.
35. Kestenbaum B, Belozeroff V. Mineral metabolism disturbances in patients with chronic kidney disease. Eur J Clin Invest. 2007. 37:607–622.
36. Locatelli F, Cannata-Andía JB, Drüeke TB, Hörl WH, Fouque D, Heimburger O, et al. Management of disturbances of calcium and phosphate metabolism in chronic renal insufficiency, with emphasis on the control of hyperphosphataemia. Nephrol Dial Transplant. 2002. 17:723–731.
37. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis. 1998. 31:607–617.
38. Young EW, Akiba T, Albert JM, McCarthy JT, Kerr PG, Mendelssohn DC, et al. Magnitude and impact of abnormal mineral metabolism in hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2004. 44:34–38.
39. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003. 42(4 Suppl 3):S1–S201.
40. Ferrari P, Singer R, Agarwal A, Hurn A, Townsend MA, Chubb P. Serum phosphate is an important determinant of corrected serum calcium in end-stage kidney disease. Nephrology (Carlton). 2009. 14:383–388.